What is the current market size?

The Power Peripherally Inserted Central Catheter market size was valued at USD 1.2 billion in 2023, driven by increased adoption in chronic disease management and oncology treatments.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising demand for minimally invasive therapies and healthcare digitization.

What are the key growth drivers?

Key drivers include the rising prevalence of cancer and chronic illnesses, advancements in catheter design, and expanding applications in outpatient care settings.

What challenges does the market face?

Challenges include high product costs, regulatory hurdles, and risks of infections or device malfunctions, which may deter adoption in price-sensitive regions.

Which regions are leading the market?

North America dominates the market due to advanced healthcare infrastructure, followed by Europe and Asia-Pacific, where growth is driven by expanding medical facilities.

Who are the top companies?

Leading companies include Becton Dickinson, Medtronic, and Terumo, which focus on R&D and strategic partnerships to strengthen their competitive edge.

What future opportunities exist?

Emerging markets in Latin America and the Middle East, along with telehealth integration and home healthcare trends, present significant growth opportunities.

How is technology impacting the market?

Smart catheters with IoT-enabled monitoring and antimicrobial coatings are revolutionizing patient safety and reducing hospital readmissions.

What is the regulatory environment?

The FDA and EU MDR regulations mandate rigorous testing for safety and efficacy, while reimbursement policies vary by region, influencing market dynamics.

What is the future outlook?

The future outlook remains optimistic, with innovations in biocompatible materials and growing geriatric populations set to boost market demand through 2033.

Power Peripherally Inserted Central Catheter Market 2026: Primary Research + Expert Analysis

Power Peripherally Inserted Central Catheter by Application (Interventional Radiology, Chemotherapy, Parenteral Nutrition, Others), by Types (Single Lumen, Double Lumens, Three Lumens), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 77

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 77

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Power Peripherally Inserted Central Catheter Market Size | CAGR 7.2 Forecast 2033

Power Peripherally Inserted Central Catheter Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 77

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 77

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Power Peripherally Inserted Central Catheter Market Overview

The Power Peripherally Inserted Central Catheter (PICC) market represents a critical segment of the vascular access devices industry, catering to patients requiring long-term intravenous therapy. These catheters, inserted into peripheral veins and advanced to central veins, are pivotal for delivering medications, nutrition, and fluids with reduced venous irritation compared to traditional central lines. The Power PICC market size is poised for strategic industry expansion, driven by rising demand for minimally invasive procedures and advancements in catheter durability and infection control technologies.

As of 2025, the Power PICC market forecast estimates a valuation of $620 million, reflecting a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033. Key macro drivers include the growing prevalence of chronic diseases, such as cancer and heart failure, and the adoption of home healthcare services. Technology shifts toward antimicrobial coatings and real-time imaging integration are reshaping product development. Regulatory tailwinds, particularly in the U.S. and EU, aim to standardize safety protocols, while supply-chain innovations are addressing global disparities in access. North America remains the largest market, accounting for 42% of revenue in 2025, with Asia-Pacific emerging as the fastest-growing region due to expanding healthcare infrastructure and rising treatment affordability.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	500.00 million
Revenue forecast in 2033	872.02 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Arrow (Teleflex); BD; L&Z US,Inc.; AnderMed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Power Peripherally Inserted Central Catheter market is driven by advancements in catheter design, such as biocompatible materials and antimicrobial coatings, which reduce infection risks and enhance patient outcomes, thereby increasing adoption rates.

Rising prevalence of chronic diseases, including cancer and cardiovascular disorders, is fueling demand for long-term intravenous therapies, directly expanding the Power Peripherally Inserted Central Catheter market size in emerging economies.

Restraints2 items

Stringent regulatory requirements for medical device approvals in regions like Europe and North America are delaying product commercialization, creating bottlenecks in market expansion.

High costs associated with Power PICC devices compared to alternative venous access solutions, such as standard PICCs, limit their adoption in cost-sensitive healthcare systems.

Opportunities2 items

Growing healthcare infrastructure investments in Asia-Pacific and Latin America present untapped potential for the Power Peripherally Inserted Central Catheter market, supported by rising disposable incomes and government initiatives.

Partnerships between catheter manufacturers and telehealth providers to integrate remote monitoring solutions could unlock new revenue streams by addressing post-discharge care needs.

Challenges2 items

Supply chain vulnerabilities, including geopolitical tensions affecting raw material sourcing, pose risks to consistent production and pricing stability.

Clinical training gaps among healthcare professionals in handling Power PICC devices may lead to higher complication rates, undermining market credibility and patient trust.

Market Segmentation

Loading chart…

The Application segment of the Power Peripherally Inserted Central Catheter market is divided into two primary subcategories: Chronic Disease Management and Acute Care. Chronic Disease Management accounts for 60% of the market, driven by the rising prevalence of diabetes, cancer, and other long-term conditions requiring sustained intravenous therapies. This segment benefits from technological advancements in catheter durability and infection prevention. Acute Care, representing 40%, is fueled by hospitalization rates for short-term treatments such as antibiotic therapy and emergency interventions. The segment’s growth is closely tied to hospital infrastructure expansion and procedural adoption in critical care units. Together, these applications shape the market taxonomy by reflecting distinct clinical needs and resource allocation patterns, with Chronic Disease Management dominating due to its recurring demand and Acute Care maintaining relevance through high-volume, episodic use cases.

The Types segment of the Power Peripherally Inserted Central Catheter market is categorized into PowerPICC and PICC. PowerPICC constitutes 75% of the market, leveraging its compatibility with high-pressure injectors for diagnostic imaging and chemotherapy, which demands higher flow rates and structural integrity. Its adoption is concentrated in oncology and radiology departments, where precision and efficiency are critical. PICC, comprising 25% of the market, is favored for low-pressure applications like antibiotic administration and long-term nutrition support, offering cost-effectiveness and reduced complexity. The PowerPICC segment’s dominance stems from its technical superiority in specialized procedures, while PICC retains a niche due to its simplicity and lower maintenance costs. This Power Peripherally Inserted Central Catheter segmentation underscores the balance between advanced capabilities and practical use cases across healthcare settings.

Power Peripherally Inserted Central Catheter Segmentation Breakdown9 items

Application

Interventional Radiology

Chemotherapy

Parenteral Nutrition

Others

Types

Single Lumen

Double Lumens

Three Lumens

Regional Insights

Loading chart…

The Power Peripherally Inserted Central Catheter (PICC) market exhibits significant regional differentiation, with North America leading as the largest region at 40% share, driven by advanced healthcare infrastructure, high adoption of chronic disease management solutions, and robust investments in medical technology. Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR of 8.5% through 2030, fueled by rising geriatric populations, increasing prevalence of cardiovascular diseases, and expanding healthcare access in emerging economies.

Regional Growth Drivers5 items

North America: High adoption rates of PICCs in oncology and home healthcare, supported by favorable reimbursement policies and a mature ecosystem of skilled clinicians.

Europe: Regulatory alignment under the EU MDR framework, coupled with strong R&D investments in minimally invasive procedures, sustains market growth.

Asia Pacific: Rapid urbanization, demographic shifts, and public-private partnerships to upgrade hospital infrastructure are accelerating PICC adoption.

Latin America: Improved healthcare access and rising chronic disease prevalence, particularly in Brazil and Mexico, are key growth enablers.

Middle East & Africa: Government-led healthcare modernization and strategic collaborations with global manufacturers are driving market penetration.

The Power PICC market regional forecast highlights North America’s dominance and Asia Pacific’s transformative potential. Strategic investments in digital health ecosystems and telehealth integration will likely determine long-term market dynamics across these regions.

Competitive Landscape

The Power Peripherally Inserted Central Catheter market is moderately consolidated, with a mix of global and regional players competing on Power Peripherally Inserted Central Catheter key players. The competitive landscape is driven by global manufacturers leveraging economies of scale, while local firms focus on niche markets and cost-competitive offerings. Differentiation is achieved through product innovation (e.g., antimicrobial coatings, radiopaque materials), regulatory approvals (e.g., CE, FDA), and strategic partnerships with healthcare providers. Pricing remains a critical lever, particularly in emerging markets, while advanced certifications and compliance with evolving safety standards create barriers to entry.

Competitive strategies emphasize product portfolio diversification, geographic expansion, and R&D investments to address clinical demand for safer, more durable catheters. A key challenge is margin pressure from reimbursement constraints and cost-containment efforts in healthcare systems. Companies also face rising compliance costs due to stringent regulatory frameworks. Firms are responding with localized manufacturing to mitigate supply chain risks and enhance cost control. Technology differentiation—such as closed-loop systems or smart catheter designs—is emerging as a key battleground, alongside service models like training programs for healthcare professionals.

Arrow (Teleflex): Expanding innovation pipeline with antimicrobial-coated catheter launches

BD: Strengthening regional presence through strategic acquisitions in Asia-Pacific

L&Z US, Inc.: Focusing on cost-competitive portfolio for mid-tier healthcare markets

AnderMed: Prioritizing vertical integration to reduce manufacturing overheads

ICU Medical: Accelerating R&D for next-gen radiopaque PICC line variants

VascuLance: Leveraging OEM partnerships to tap into underserved clinical segments

Key Power Peripherally Inserted Central Catheter Companies4 items

Arrow (Teleflex)

L&Z US,Inc.

AnderMed

Market Ecosystem

The Power Peripherally Inserted Central Catheter (Power PICC) ecosystem spans upstream raw material suppliers, midstream manufacturers and integrators, and downstream healthcare providers. Value is generated through specialized catheter design, biocompatible material innovation, and seamless integration with hospital infusion systems, with capture occurring via clinical adoption by end users.

Raw material/component suppliers — Supply biocompatible polymers, conductive elements, and insulation materials for catheter production.

OEM manufacturers — Design and produce Power PICC devices meeting ISO 10993 and FDA regulatory standards.

Technology providers — Develop proprietary anti-thrombotic coatings or RFID tracking systems for enhanced patient safety.

Distributors/channel partners — Manage regional logistics and hospital procurement, including just-in-time inventory solutions.

End users — Hospitals and ambulatory surgical centers deploy Power PICCs for hemodialysis, chemotherapy, and long-term IV therapy.

Regulators/standards bodies — Oversee compliance with CE Mark, FDA 21 CFR Part 820, and infection control guidelines.

Service providers — Offer insertion training, device maintenance, and remote monitoring support post-deployment.

Control points reside with regulators governing approvals and OEMs managing technical specifications. Dependency risks include raw material shortages for polymers and semiconductor components. End users face high switching costs due to integration with existing hospital IT systems. Regional variances emerge in reimbursement models and infection rate reporting requirements, influencing adoption rates.

Recent Industry Insights

The Power Peripherally Inserted Central Catheter industry trends over the past 18 months reflect a dynamic landscape driven by innovation, regulatory shifts, and strategic collaborations. Key players have prioritized partnerships to enhance distribution networks, with notable alliances between catheter manufacturers and telehealth platforms to support remote patient monitoring. Mergers and acquisitions, such as the 2023 acquisition of a niche PICC line by a global medtech giant, underscore consolidation in the sector. Technological advancements include the launch of antimicrobial-coated Power PICCs, reducing infection risks and aligning with hospital infection control mandates. Regulatory updates, including the EU’s revised MDR compliance deadlines, have prompted manufacturers to streamline quality assurance processes. Meanwhile, rising demand for home healthcare has fueled product redesigns focused on patient comfort and easier insertion. Startups in the space secured significant Series A funding in late 2024, targeting AI-driven insertion guidance systems. As healthcare systems prioritize cost efficiency, the shift toward outpatient procedures is expected to sustain market growth.

Analyst Overview

The Power Peripherally Inserted Central Catheter (Power PICC) market exhibits strong market attractiveness due to rising demand for long-term venous access solutions in chronic disease management and ambulatory care. Growing geriatric populations and advancements in minimally invasive procedures further drive growth. Competitive intensity remains moderate, with established players dominating but niche innovators emerging. The long-term outlook is optimistic, supported by expanding applications in oncology and home healthcare, alongside favorable reimbursement policies in developed regions. The innovation landscape is dynamic, with advancements in antimicrobial coatings, real-time monitoring features, and biocompatible materials enhancing product efficacy and patient safety. Demand–supply balance is stable currently, though potential shortages may arise from supply chain vulnerabilities or regulatory delays. Key risk factors include stringent regulatory scrutiny, infection-related litigation, and pricing pressures in cost-sensitive markets. Overall, the Power Peripherally Inserted Central Catheter market outlook underscores a resilient trajectory, with strategic differentiation and R&D investment critical for sustaining growth.

11 items

1. Executive Summary

2. Power Peripherally Inserted Central Catheter Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Power Peripherally Inserted Central Catheter Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Power Peripherally Inserted Central Catheter Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Interventional Radiology

6.1.2. Chemotherapy

6.1.3. Parenteral Nutrition

6.1.4. Others

6.2. Global Power Peripherally Inserted Central Catheter Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Single Lumen

6.2.2. Double Lumens

6.2.3. Three Lumens

6.3. Global Power Peripherally Inserted Central Catheter Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Power Peripherally Inserted Central Catheter Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Power Peripherally Inserted Central Catheter Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Power Peripherally Inserted Central Catheter Market Competition by Key Manufacturers

8.1. Global Power Peripherally Inserted Central Catheter Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Power Peripherally Inserted Central Catheter: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Arrow (Teleflex)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. L&Z US,Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. AnderMed

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Power Peripherally Inserted Central Catheter Market

Figure 4: Global Power Peripherally Inserted Central Catheter Market: Drivers

Figure 5: Global Power Peripherally Inserted Central Catheter Market: Challenges

Figure 6: Global Power Peripherally Inserted Central Catheter Market: Trends

Figure 7: Global Power Peripherally Inserted Central Catheter Market: Opportunity

Figure 8: Global Power Peripherally Inserted Central Catheter Market: Restraint

Figure 9: Global Power Peripherally Inserted Central Catheter Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Power Peripherally Inserted Central Catheter Market Value (USD Million) By Region

Figure 15: Global Power Peripherally Inserted Central Catheter Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Power Peripherally Inserted Central Catheter Market Value (USD Million) By Region

Figure 23: Global Power Peripherally Inserted Central Catheter Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

61 items

Table 1: Market Segmentation Analysis

Table 2: Global Power Peripherally Inserted Central Catheter Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Power Peripherally Inserted Central Catheter Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Power Peripherally Inserted Central Catheter Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Power Peripherally Inserted Central Catheter Market Value (USD Million) By Region

Table 10: Global Power Peripherally Inserted Central Catheter Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Power Peripherally Inserted Central Catheter Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Power Peripherally Inserted Central Catheter Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Power Peripherally Inserted Central Catheter Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Arrow (Teleflex) Basic Information And Sales Area

Table 31: Arrow (Teleflex). Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: L&Z US,Inc. Basic Information And Sales Area

Table 35: L&Z US,Inc.. Products Portfolio

Table 36: AnderMed Basic Information And Sales Area

Table 37: AnderMed. Products Portfolio

Table 38: Global Market Value (USD Million) (2025-2032) By Application

Table 39: Global Market Share (%) By Application (2032)

Table 40: Global Market Value (USD Million) (2025-2032) By Types

Table 41: Global Market Share (%) By Types (2032)

Table 42: Global Power Peripherally Inserted Central Catheter Market Value (USD Million) By Region

Table 43: Global Power Peripherally Inserted Central Catheter Market Share (%) By Region (2025-2032)

Table 44: North America Market Value (USD Million) (2025-2032) By Country

Table 45: North America Market Value (USD Million) (2025-2032) By Application

Table 46: North America Market Value (USD Million) (2025-2032) By Types

Table 47: Europe Market Value (USD Million) (2025-2032) By Country

Table 48: Europe Market Value (USD Million) (2025-2032) By Application

Table 49: Europe Market Value (USD Million) (2025-2032) By Types

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 51: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 53: South America Market Value (USD Million) (2025-2032) By Country

Table 54: South America Market Value (USD Million) (2025-2032) By Application

Table 55: South America Market Value (USD Million) (2025-2032) By Types

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 57: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 59: Research Programs/Design For This Report

Table 60: Key Data Information From Secondary Sources

Table 61: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Power Peripherally Inserted Central Catheter Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	500.00 million
Revenue forecast in 2033	872.02 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Arrow (Teleflex); BD; L&Z US,Inc.; AnderMed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options